Skip to main content
. 2021 Oct 18;2021:5577541. doi: 10.1155/2021/5577541

Figure 1.

Figure 1

Plasma levels of oxidative stress markers at baseline and after 3 months of treatment in the placebo and melatonin groups. (a) Lipoperoxides (malonaldehyde + 4 hydroxyalkenes), (b) nitric oxide metabolites (nitrates and nitrites), (c) carbonyl groups in proteins, and (d) catalase enzyme activity. Data of the mean ± standard error and a p < 0.05 are shown.